The U.S. FDA granted NuVasive Inc. clearance for its CoRoent small interbody system, indicated for intervertebral body fusion at multiple contiguous levels in the cervical spine.
The cervical cage is intended for the treatment of multilevel cervical disc degeneration in patients displaying cervical radiculopathy and myelopathy. The device provides stabilization of the spinal motion segment while fusion takes place.
The implants included in the clearance are CoRoent small, CoRoent small lordotic, CoRoent small lordotic plus, CoRoent small hyperlordotic and CoRoent small contoured.
The FDA approval is the first U.S. clearance for the use of a cervical cage at up to four contiguous levels.